Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RYGB Improves Metabolism by Interrupting the Gastric Adipose Tissue Axis

NCT01474785 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT01474785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01474785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RYGB Improves Metabolism by Interrupting the Gastric Adipose Tissue Axis
Lead sponsor
Vanderbilt University
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2012
Completion date
July 31, 2015
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity